tiprankstipranks

New Portfolio - New Portfolio

Roy Ifebhor

New Portfolio
Individual Investor
Ranked #483,173 out of 730,435 TipRanks' Investors
Success Rate
38%
77 out of 201
profitable transactions
Average Return
-10.81%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 0.89%
6-Month Return▲ 5.31%
12-Month Return▼ 0.33%
YTD Return▼ 3.73%
Total Return▼ 61.86%

Best Trade

Opened at
Closed at
Gain▲ 103.45%

Bio

Performance

18.13%0-18.13%
▼ 4.52%
▼ 4.74%
▼ 3.14%
Sep 2023
▼ 6.45%
▼ 2.17%
▼ 9.64%
Oct 2023
▲ 9.22%
▲ 9.13%
▲ 5.77%
Nov 2023
▲ 5.14%
▲ 4.57%
▲ 4.37%
Dec 2023
▼ 1.87%
▲ 1.59%
▼ 2.18%
Jan 2024
▲ 14.08%
▲ 5.22%
▼ 0.35%
Feb 2024
▲ 5.05%
▲ 3.27%
▲ 2.02%
Mar 2024
▼ 18.13%
▼ 3.38%
▼ 3.19%
Apr 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 4.52%▼ 4.74%▼ 3.14%
▼ 6.45%▼ 2.17%▼ 9.64%
▲ 9.22%▲ 9.13%▲ 5.77%
▲ 5.14%▲ 4.57%▲ 4.37%
▼ 1.87%▲ 1.59%▼ 2.18%
▲ 14.08%▲ 5.22%▼ 0.35%
▲ 5.05%▲ 3.27%▲ 2.02%
▼ 18.13%▼ 3.38%▼ 3.19%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
6sv95boiy
6sv95boiy
6sv95boiy
6sv95boiy
6sv95boiy
6sv95boiy
6sv95boiy
mic5fhfo
mic5fhfo
mic5fhfo
mic5fhfo
mic5fhfo
mic5fhfo
mic5fhfo
ryj64q3cp2
ryj64q3cp2
ryj64q3cp2
ryj64q3cp2
ryj64q3cp2
ryj64q3cp2
ryj64q3cp2
egzyl3cnijj
egzyl3cnijj
egzyl3cnijj
egzyl3cnijj
egzyl3cnijj
egzyl3cnijj
egzyl3cnijj
qk34a2iqrqb
qk34a2iqrqb
qk34a2iqrqb
qk34a2iqrqb
qk34a2iqrqb
qk34a2iqrqb
qk34a2iqrqb
o49eot
o49eot
o49eot
o49eot
o49eot
o49eot
o49eot
yrd8mrkw
yrd8mrkw
yrd8mrkw
yrd8mrkw
yrd8mrkw
yrd8mrkw
yrd8mrkw
38sm30x
38sm30x
38sm30x
38sm30x
38sm30x
38sm30x
38sm30x
mlnf9u0d
mlnf9u0d
mlnf9u0d
mlnf9u0d
mlnf9u0d
mlnf9u0d
mlnf9u0d
ci3pvvp91
ci3pvvp91
ci3pvvp91
ci3pvvp91
ci3pvvp91
ci3pvvp91
ci3pvvp91
To view investors' portfolios
Sign Up For Free
BP Prudhoe Bay
▼ 18.36%
6
Close
Apr 28, 2023
CVR Partners
▼ 7.11%
4
Close
Apr 28, 2023
Party City Holdco
▼ 98.03%
5
Close
Apr 28, 2023
AquaBounty Technologies
▼ 42.95%
2
Close
Apr 28, 2023
United States Antimony
▼ 16.39%
2
Close
Apr 28, 2023
Spero Therapeutics
▲ 103.45%
2
Close
Apr 28, 2023
Stryve Foods
▼ 2.41%
3
Close
Apr 28, 2023
Salarius Pharmaceuticals
▼ 70.33%
2
Close
Apr 28, 2023
SeaChange International
▼ 14.42%
2
Close
Apr 28, 2023
NextTrip
▼ 56.29%
2
Close
Apr 28, 2023
Qualigen Therapeutics
▼ 70.47%
2
Close
Apr 28, 2023
Unicycive Therapeutics
▲ 89.23%
2
Close
Apr 28, 2023
Paramount Gold Nevada
▼ 2.57%
2
Close
Apr 28, 2023
Predictive Oncology
▼ 65.36%
2
Close
Apr 28, 2023
Oragenics
▼ 83.87%
2
Close
Apr 28, 2023
NexImmune
▼ 44.28%
2
Close
Apr 28, 2023
ENDRA Life Sciences
▼ 76.47%
2
Close
Apr 28, 2023
NeuBase Therapeutics
▼ 72.99%
2
Close
Apr 28, 2023
Perspective Therapeutics
▲ 83.48%
2
Close
Apr 28, 2023
Intelligent Bio Solutions
▼ 73.33%
2
Close
Apr 28, 2023